// App-Quantinova.ai

3078 : GSK-3 inhibitor 9ING41 potentiates the antitumor effects of CPT-11 in human breast cancer

Researchers

Presenter

  • Andrey Ugolkov

Principal Investigators

  • Irina Gaisina

  • Kevin White

  • Alan Kozikowski

  • Thomas OHalloran

  • Andrew Mazar

Medical Centers

  • Northwestern University, Evanston, IL

  • University of Illinios at Chicago, Chicago, IL

  • The University of Chicago Medical Center, Chicago, IL

  • University of Illinios at Chicago, Chicago, IL

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

  • Solid malignancies

Biomarkers

  • Estrogen Receptor 1

Drug/Treatment

  • Alora

  • Cisplatin

  • Tamoxifen

  • Irinotecan

  • Adrucil injection

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved